The FDA’s 2026 Human Foods Program (HFP) deliverables signal a significant pivot toward “Make America Healthy Again” (MAHA). For manufacturers, the most critical change is the proposed rule to mandate Generally Recognized as Safe (GRAS) notices, effectively ending the era of self-GRAS marketing.
As the FDA intensifies its post-market safety reviews of food chemicals and additives, salt alternatives will face higher scrutiny. Manufacturers must now prioritize ingredients with proven safety profiles and scalable technology to avoid the risk of sudden regulatory non-compliance. MicroSalt® provides a proactive solution: a patented technology that reduces sodium by up to 50% using real salt, aligning perfectly with the HFP’s mission to reduce diet-related chronic disease without the “red tape” of unproven chemical alternatives.
Market Momentum
The reduced-salt packaged food market is projected to soar from $13.35 billion in 2025 to $25 billion by 2035, driven by a massive surge in health-conscious consumer demand. Read more.
Labeling preasures
In Canada, new mandatory front-of-package (FOP) warning labels are driving a wave of “pre-emptive reformulation” as brands strive to avoid high-sodium identifiers on their products. Read more.
The taste paradox
While 67% of consumers choose foods for health benefits, many remain skeptical that “healthy” indulgence can truly deliver on flavor. Read more.
